Choueiri TK - Search Results

1

Linking a Trio of Molecular Features in Clear-Cell Renal Cell Carcinoma.

Labaki C, Van Allen EM, Choueiri TK. Labaki C, et al. Among authors: choueiri tk. Cancer Immunol Res. 2022 Mar 1;10(3):274. doi: 10.1158/2326-6066.CIR-22-0058. Cancer Immunol Res. 2022. PMID: 35131809

2

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI, Bukowski RM. Choueiri TK, et al. Cancer. 2007 Aug 1;110(3):543-50. doi: 10.1002/cncr.22827. Cancer. 2007. PMID: 17577222 Free article.

3

Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agents.

Choueiri TK. Choueiri TK. Clin Genitourin Cancer. 2008 Mar;6(1):15-20. doi: 10.3816/CGC.2008.n.002. Clin Genitourin Cancer. 2008. PMID: 18501077 Review.

4

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.

Rini BI, Choueiri TK, Elson P, Khasawneh MK, Cotta C, Unnithan J, Wood L, Mekhail T, Garcia J, Dreicer R, Bukowski RM. Rini BI, et al. Among authors: choueiri tk. Cancer. 2008 Sep 15;113(6):1309-14. doi: 10.1002/cncr.23711. Cancer. 2008. PMID: 18618496 Free article.

5

von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.

Choueiri TK, Vaziri SA, Jaeger E, Elson P, Wood L, Bhalla IP, Small EJ, Weinberg V, Sein N, Simko J, Golshayan AR, Sercia L, Zhou M, Waldman FM, Rini BI, Bukowski RM, Ganapathi R. Choueiri TK, et al. J Urol. 2008 Sep;180(3):860-5; discussion 865-6. doi: 10.1016/j.juro.2008.05.015. Epub 2008 Jul 17. J Urol. 2008. PMID: 18635227

6

Treatment selection for patients with metastatic renal cell carcinoma.

Atkins MB, Choueiri TK, Cho D, Regan M, Signoretti S. Atkins MB, et al. Among authors: choueiri tk. Cancer. 2009 May 15;115(10 Suppl):2327-33. doi: 10.1002/cncr.24231. Cancer. 2009. PMID: 19402069 Free PMC article. Review.

7

A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib.

Choueiri TK, Mosquera JM, Hirsch MS. Choueiri TK, et al. Clin Genitourin Cancer. 2009 Oct;7(3):E93-4. doi: 10.3816/CGC.2009.n.031. Clin Genitourin Cancer. 2009. PMID: 19815489

8

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.

Choueiri TK, Regan MM, Rosenberg JE, Oh WK, Clement J, Amato AM, McDermott D, Cho DC, Atkins MB, Signoretti S. Choueiri TK, et al. BJU Int. 2010 Sep;106(6):772-8. doi: 10.1111/j.1464-410X.2010.09218.x. Epub 2010 Mar 2. BJU Int. 2010. PMID: 20230385

9

Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.

Choueiri TK, Lim ZD, Hirsch MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM. Choueiri TK, et al. Cancer. 2010 Nov 15;116(22):5219-25. doi: 10.1002/cncr.25512. Cancer. 2010. PMID: 20665500 Free PMC article.

10

Sunitinib rechallenge in metastatic renal cell carcinoma patients.

Zama IN, Hutson TE, Elson P, Cleary JM, Choueiri TK, Heng DY, Ramaiya N, Michaelson MD, Garcia JA, Knox JJ, Escudier B, Rini BI. Zama IN, et al. Among authors: choueiri tk. Cancer. 2010 Dec 1;116(23):5400-6. doi: 10.1002/cncr.25583. Epub 2010 Nov 2. Cancer. 2010. PMID: 21105118 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

790 results

Search Page